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Abstract
Background: While G6PD deficiency is one of the major causes of acute hemolytic anemia, the membrane changes leading
to red cell lysis have not been extensively studied. New findings concerning the mechanisms of G6PD deficient red cell
destruction may facilitate our understanding of the large individual variations in susceptibility to pro-oxidant compounds
and aid the prediction of the hemolytic activity of new drugs.
Methodology/Principal Findings: Our results show that treatment of G6PD deficient red cells with diamide (0.25 mM) or
divicine (0.5 mM) causes: (1) an increase in the oxidation and tyrosine phosphorylation of AE1; (2) progressive recruitment of
phosphorylated AE1 in large membrane complexes which also contain hemichromes; (3) parallel red cell lysis and a massive
release of vesicles containing hemichromes. We have observed that inhibition of AE1 phosphorylation by Syk kinase
inhibitors prevented its clustering and the membrane vesiculation while increases in AE1 phosphorylation by tyrosine
phosphatase inhibitors increased both red cell lysis and vesiculation rates. In control RBCs we observed only transient AE1
phosphorylation.
Conclusions/Significance: Collectively, our findings indicate that persistent tyrosine phosphorylation produces extensive
membrane destabilization leading to the loss of vesicles which contain hemichromes. The proposed mechanism of
hemolysis may be applied to other hemolytic diseases characterized by the accumulation of hemoglobin denaturation
products.
Citation: Pantaleo A, Ferru E, Carta F, Mannu F, Simula LF, et al. (2011) Irreversible AE1 Tyrosine Phosphorylation Leads to Membrane Vesiculation in G6PD
Deficient Red Cells. PLoS ONE 6(1): e15847. doi:10.1371/journal.pone.0015847
Editor: Hendrik W. van Veen, University of Cambridge, United Kingdom
Received August 6, 2010; Accepted November 25, 2010; Published January 5, 2011
Copyright:  2011 Pantaleo et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits
unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Funding: Regione Sardegna had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Nurex srl: FM and FC
(owner and employee of Nurex) voluntarily participated to the study because of their long standing interest in the field of red cell membrane biology. Nurex
supported the work allowing the use of different equipments such as mass spectrometry and HPLCs and therefore did have a role in experimental design andi n
data collection and analysis but had no role in the decision to publish, or preparation of the manuscript.
Competing Interests: The authors have declared that no competing interests exist.
* E-mail: francesco.turrini@unito.it
Introduction
G6PD deficiency affects more than 400 million people
worldwide, with a prevalence varying from 10 to 25% in most
areas where malaria is endemic. This genetic defect provides
partial protection against malaria, but may lead to severe
hemolytic episodes after the administration of some drugs (anti-
malarials, anti-inflammatories, vitamin K, etc.), the ingestion of
fava beans (favism) or infection [1–3]. Typically the appearance of
the first symptoms occurs 24–48 hours after the intake of pro-
oxidant drugs or fava beans.
While the molecular biology of G6PD deficiency has been
extensively studied [2], the molecular mechanisms leading to the
hemolytic crisis are still unclear. G6PD deficient red cells (G
2
RBCs) display a failure of the protective response to oxidant stress,
which leads to irreversible oxidation of glutathione [1,2,4–6]. The
accumulation of large hemichrome aggregates (Heinz bodies) is an
additional hallmark of the hemolytic crisis in G
2 individuals [7].
Some membrane alterations have been described in G
2 RBCs,
such as the oxidation and clustering of membrane proteins, the
binding of hemichromes to the internal face of the membrane, the
destabilization of the membrane and the release of micro-vesicles
[8–10]. Interestingly, increased hemichrome formation has been
observed in G
2 RBCs infected by malaria parasites [11]. The data
available on membrane modifications are in any case insufficient
to formulate a clear hypothesis as to the mechanisms of membrane
destabilization and G
2 RBC destruction. The dearth of
information concerning the mechanisms of red cell lysis represents
a practical drawback which impedes both any prediction about the
hemolytic activity of drugs and the understanding of the large
individual susceptibility even in presence of the same G6PD
mutation [1].
The authors, as well as others have shown that band 3 red cell
membrane protein (AE1) displays a marked tendency to become
tyrosine phosphorylated in G- RBCs after –SH group oxidation
or GSH depletion by 1-chloro-2,4-dinitrobenzene (CDNB) or
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kinase strongly increases its affinity to oxidized AE1 and induces
its selective phosphorylation [13]. Hyper-phosphorylated AE1
showed a manifest tendency to cluster, indicating a change in its
interactions with the cytoskeletal network. Furthermore, abnormal
AE1 tyrosine phosphorylation has been observed in a number of
red cell disorders [14].
In the present study we have demonstrated that following –SH
group oxidation induced by diamide (–SH group oxidant) and
divicine, an oxygen reactive compound held responsible for favism
[15], AE1 becomes increasingly and irreversibly phosphorylated
in G
2 RBCs. Syk kinase inhibition largely prevents red cell
membrane lysis and vesiculation, strongly suggesting a functional
role of AE1 tyrosine phosphorylation in the red cell membrane
destabilization.
Results
Short and long term effects of oxidants in G6PD deficient
red cells
Previous work has described how oxidant treatments induce
more intense AE1 tyrosine phosphorylation in G
2 RBCs than in
control RBCs [13,14,16]. In the present study, we analyzed AE1
phosphorylation and a series of additional parameters for longer
time exposure with diamide, an -SH group oxidant reagent, or with
divicine [15], a compound extracted from fava beans considered
responsible for severe hemolytic crises in G
2 deficient subjects
[5,15]. The long term effects of oxidants in the G
2 RBCs were not
easily predictable as, although the G
2 RBC samples used in our
experiments had low G6PD levels (Mediterranean variant 563 C
—. T with approximately 2–3% of normal red cell G6PD activity
level), the hexose monophosphate shunt activity in these cells
presented normal activity and could be 2–3 fold further activated
following oxidant treatments [17].
Following 0.25 mM treatment with diamide, approximately
80% of reduced glutathione (GSH) was oxidized within 5 minutes
and the pre-treatment levels were restored within 45 minutes in
control RBCs. Conversely, in G
2 RBCs reduced GSH further
declined and reached un-measurable levels within 2 hours of
incubation (Fig. 1A). Indistinguishable GSH response was elicited
by divicine 0.5 mM. On the basis of these results we decided to use
these concentrations both for diamide and divicine.
Figure 1C shows that following oxidant treatment, in G
2 RBCs,
AE1 phosphorylation progressively increased during the course of
incubation (10 hours). In control RBCs AE1 phosphorylation was
completely reverted in approximately 1 hour. Syk kinase inhibitors
markedly reduced the rate of AE1 phosphorylation both in control
and G
2 RBCs. AE1 oxidation (disulfide cross-linking) parallels its
tyrosine phosphorylation both in control and G
2 RBCs (Fig. 1D).
As expected Syk inhibitors did not exert an apparent effect on AE1
oxidation.
Figure 1E shows that following oxidant treatment, in G
2 RBCs,
AE1 was increasingly recruited in a high molecular weight cluster
[13,18], while in control RBCs, AE1 clustering showed transient
behavior. AE1 large cluster formation appeared to be delayed in
comparison to the AE1 phosphorylation and oxidative cross-
linking. Syk kinase inhibitors decreased the amount of clustered
AE1. Analysis of the clustered AE1 fraction revealed that AE1 was
prevalently oxidized, cross-linked and phosphorylated. Anti-Syk
western blot revealed a time dependent increase of Syk associated
with the high molecular weight fraction. In the same fraction we
observed the presence of hemoglobin denaturation products (see
below).
Figure 1B shows that the hemichrome quantities measured in
isolated RBC membranes increased with time after oxidant
treatment of G
2 RBCs. In control RBCs no hemichrome
formation was observed. Syk inhibitors did not exert an apparent
effect on hemichrome formation. Measuring the hemichromes also
in the high molecular weight clusters, we have estimated that
approximately 75% of hemichromes were associated with this
membrane protein complex.
At the chosen concentrations, diamide and divicine caused very
similar effects in all monitored parameters indicating that the long
term effects of divicine are probably triggered by sulfidril groups
oxidation.
In conclusion, this set of results indicates that even after long
term incubation, G
2 RBCs are unable to restore the initial levels
of GSH and, consequently, to reduce the disulfide bonds of AE1.
In G
2 RBCs, AE1 tyrosine phosphorylation and clustering also
increase with time after oxidant treatment. Syk inhibitors cause a
marked reduction of both AE1 phosphorylation and clustering
without effecting its oxidative cross-linking and hemichrome
formation, suggesting that persistent AE1 phosphorylation plays
a role in the formation of the large membrane complexes.
Effect of Syk kinase and PTP inhibitors on G6PD deficient
red cell lysis caused by oxidant treatments
Observing the supernatant of G
2 RBC culture we noticed a
marked lysis some hours after the exposure to oxidants. No
hemolysis was observed in control RBCs. Figure 2A shows that red
cell lysis became evident after 2–3 hours of incubation in G
2
RBCs, increasing progressively with the time. Pre-treatment with
Syk kinase inhibitors caused a consistent reduction of the
hemolysis, while phosphatase inhibition by o-vanadate caused an
accelerated and more intense hemoglobin leakage indicating an
association between G
2 RBCs lysis and AE1 phosphorylation
levels (Fig. 2B).
Confocal microscopy analysis revealed that oxidant exposure
induced marked changes exclusively in G
2 RBCs. Following a
2 hour incubation with diamide 0.25 mM, hemichrome formation
was already observable: staining with both AE1 and anti-
phosphotyrosine antibodies revealed an uneven membrane
distribution and an apparent co-association with the hemichrome
clusters (Fig. 3). Hemichromes and tyrosine phosphorylation were
not observed in control RBCs treated in the same conditions.
Characterization of membrane vesicles released from
G6PD deficient red cells following oxidant treatments
Vesicles were isolated from red cell cultures (4 hours of
incubation with diamide 0.25 mM) by ultra-centrifugation and
then characterized by confocal analysis of hemichrome auto-
fluorescence, western blotting and mass spectrometry. Confocal
microscopy analysis was suggestive of large amounts of hemi-
chromes in isolated vesicles (Fig. 4A). The presence of hemi-
chromes in isolated vesicles was further demonstrated by Vis
spectrometry analysis indicating that a large fraction (approxi-
mately 90%) of hemoglobin contained in the vesicles, was present
in the form of hemichromes (data not shown). SDS-PAGE
separation of vesicle proteins and the identification by mass
spectrometry of the more prominent bands, further supported the
presence of large amounts of hemoglobin products (Fig. 4B).
Western blotting analysis of isolated vesicles demonstrated that
they contained oxidized, cross-linked and phosphorylated AE1
(Fig. 4C). The quantitative measurement of AE1 evidenced the
time course of vesicle release. A marked reduction of vesicle release
was observed following Syk inhibitor treatment (Fig. 4D).
AE1 Phosphorylation in G6PD Deficient Red Cells
PLoS ONE | www.plosone.org 2 January 2011 | Volume 6 | Issue 1 | e15847Figure 1. Time course of AE1 tyrosine phosphorylation, oxidation and clustering. GSH levels measured in control (CTRL) and G6PD
deficient (G
2) RBCs upon diamide treatment, expressed as mM (Fig. 1A). Amounts of hemichromes (HMC) measured in isolated membranes of control
and G6PD deficient RBCs (Fig. 1B). HMCs were quantified by Vis spectrometry and expressed as nmoles/ml. Quantitative densitometry of AE1
phosphorylation levels (Fig. 1C) and of the oxidatively cross-linked AE1 (Fig. 1D) in control and G
2 RBCs. Quantification of AE1 phosphorylation levels
and of oxidized AE1 was performed with an IR fluorescence detection scanner (Odyssey, Licor, USA) of anti-phosphotyrosine (apTyr) and anti-AE1
AE1 Phosphorylation in G6PD Deficient Red Cells
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In a previous study [13] we observed that AE1 phosphorylation
was apparently more pronounced and long standing in G
2 RBCs
than in control RBCs following their treatment with diamide but,
after a short incubation time, we did not observe any functional
consequence. Hemolytic crises in G
2 subjects occur many hours
after the intake of pro-oxidant compounds [7], therefore, in the
present study we investigated the long term effects (up to 10 hours)
of the treatment of G
2 RBCs with diamide (an -SH group oxidant
reagent) or divicine (a compound extracted from fava beans held
responsible for severe hemolytic crises in G
2 deficient subjects)
[15].
The treatment with these compounds caused similar short term
effects in G
2 and control RBCs but after 2–3 hours of incubation,
striking differences were observed between the two types of red
cells. While control RBCs returned to the pre-treatment
conditions, G
2 RBCs showed a time dependent modification of
several parameters: i) the GSH levels and -SH groups of AE1
continued to decrease; ii) Syk tyrosine kinase became irreversibly
associated with the membrane; iii) AE1 tyrosine phosphorylation
steadily increased over time, iv) hemichromes became progres-
sively bound to the membrane; v) phosphorylated AE1 formed
large clusters; vi) these clusters were exovesiculated and this
phenomenon was associated with lysis.
We have observed that Syk inhibitors consistently reduced the
amount of vesiculation and lysis. The protective effect of Syk
inhibitors suggested that, in G
2 RBCs, AE1 hyper-phosphoryla-
tion may play a role in the progressive membrane damage induced
by oxidant treatments.
This hypothesis is supported by some additional findings: i) o-
vanadate (tyrosine phosphatase inhibitor) further increased AE1
phosphorylation and the rate of vesicle release, ii) we have isolated
membrane protein complexes which contain both hemichromes
and phosphorylated AE1, iii) confocal microscopy confirmed the
co-association between hemichromes and phosphorylated AE1, iv)
vesicles isolated from G
2 RBCs revealed their high content of
hemichromes and phosphorylated AE1.
The present findings are in accordance with previous results
which have demonstrated that Syk kinase binds preferentially to
oxidized AE1, inducing its tyrosine phosphorylation [13].
Increased red cell membrane fragility has often been associated
with membrane vesiculation in different hematological situations
[19–21]. It is interesting to note that the clustering of AE1 through
its binding to hemichromes has been demonstrated in most of
these conditions [22–29]. Moreover, in hemolytic diseases, the
accumulation of vesicles derived from the red cell membranes has
received particular consideration because of their potential pro-
coagulant and pro-inflammatory activities [30,31]. No direct data
about vesicle accumulation in the plasma of G
2 subjects
undergoing hemolysis are currently available, but the presence
of high levels of hemoglobin in the plasma strongly suggests the
occurrence of intravascular hemolysis due to red cell membrane
instability [7].
In conclusion, the present study contributes to the understand-
ing of the mechanism of membrane destabilization and vesicle
Figure 2. Time course of G6PD deficient RBC lysis. A. Quantification of haemoglobin released from G6PD deficient (G
2) RBCs that were treated
with 0.25 mM diamide (Dia) in presence or absence of Syk inhibitors 10 mM (Syk I.) and o-vanadate 1 mM (OV) at different incubation times (0–600
minutes). Values are means of 3 experiments and are expressed as nmoles/ml. The changes caused by Syk inhibitors (after 120 minutes) and OV (after
60 minutes) were significant (p,0.01). B. Anti band 3 (aBd3) and anti-phosphotyrosine (apTyr) western blots of G
2 RBCs treated with diamide
0.25 mM (lanes 1 and 2) in absence or presence of Syk inhibitors (lane3) or o-vanadate (lane 4). Membrane proteins were solubilized in presence of
the reducing agent (DTT).
doi:10.1371/journal.pone.0015847.g002
(aBd3) western blots with Odyssey V3.0 software and expressed as fluorescence arbitrary units. The western blots in figure 1C and 1D show the areas
used for AE1 tyrosine phosphorylation and oxidation quantifications. Membrane proteins were solubilized in presence (Fig. 1C) or absence (Fig. 1D) of
the reducing agent (DTT). Percentages of clustered AE1 after gel filtration separation of the high molecular weight protein complexes (Fig. 1E).
Membrane proteins were extracted from control and G6PD deficient RBCs by 1% triton-X100, the supernatant was applied to a 4061 cm column
filled with Sepharose CL-6B to isolate the high molecular weight membrane protein complexes. AE1 was quantified by eosine maleimide fluorescence
detection. Clustered AE1 was quantified as percentage of total AE1 eluted from the column. The chromatogram in figure 1E shows the two peaks
corresponding to clustered and non-clustered AE1. The western blots in figure 1E show the presence of aggregated AE1 (aBd3), its tyrosine
phosphorylation (apTyr) and Syk (aSyk) in the high molecular weight fraction. Membrane proteins were solubilized in absence (lanes 1 and 2) or in
presence (lane 3) of the reducing agent (DTT). Control and G6PD deficient RBCs were treated with 0.25 mM diamide (Dia) in presence or absence of
Syk inhibitors 10 mM (Syk I.) at different incubation times (0–600 minutes). Values are means of 3 experiments. All differences observed between
control and G6PD deficient RBCs were significant (p,0.01). In Figure 1C and 1E (only in G6PD deficient and after 60 minutes) the changes caused by
Syk inhibitors were significant (p,0.01).
doi:10.1371/journal.pone.0015847.g001
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2 RBCs with oxidant
compounds (Fig. 5). As malaria parasites have been demonstrated
to exert both oxidative damage and the binding of hemichromes to
the red cell membrane [23,32] it will be of great interest to verify
whether the membrane alterations described herein may also be
promoted by malaria parasites. In this case, the data presented
may contribute to an explanation of the mechanism of malaria
protection in G6PD deficient subjects.
AE1 clusters are known to bind naturally occurring antibodies
and to trigger red cell phagocytosis [33,34]. These phenomena
may enhance the removal of vesicles which contain hemichromes,
however, the role of antibodies and splenic macrophages has yet to
be elucidated. In this respect, the functional meaning of the
proposed mechanism in the selective removal of hemichromes
from red cell membrane Vs the induction of membrane instability
responsible for red cell lysis is to be clarified.
Additional studies will be required to further define a series of
events such as: the irreversibility of AE1 tyrosine phosphorylation;
the relative contributions of Syk kinase activation [12,35–37] and
tyrosine phosphatase inhibition [38–40]; the changes of AE1 –
cytoskeleton interactions induced by AE1 phosphorylation; and
the effect of additional membrane protein modifications [33].
Materials and Methods
Treatment of RBCs
Venous blood was drawn from 5 healthy and 5 G6PD deficient
volunteers (Mediterranean variant 563 C —. T with approxi-
mately 2–3% of normal red cell G6PD activity level). Written
informed consent was obtained from each blood donor to allow:
‘‘The use of 10 ml of their blood donation for research use. In
particular, to study the causes of hemolytic episodes in G6PD
deficient subjects’’. Ethical approval to perform the present study
was obtained from the ‘‘Ethical Committee of the ASL 1 –
Sassari’’. The data were analyzed anonymously and all clinical
investigation was conducted according to the principal expressed
in the Declaration of Helsinki. None of the donors showed clinical
and laboratory evidence of hemolysis and all presented hemoglo-
bin levels within the normal range. G6PD deficiency assessment
was performed as previously described [22]. Red cells were
pelleted at 1,0006 g for 10 min at room temperature. After
removal of the buffy coat, red blood cells (RBCs) were again
pelleted and washed 36 with phosphate buffer saline (137 mM
NaCl, 2.7 mM KCl, 8.1 mM K2HPO4, 1.5 mM KH2PO4,
pH 7.4) in presence of 5 mM glucose (PBS-glucose) to obtain
packed cells. To simulate oxidative stress, RBCs at 30%
hematocrit were treated for different incubation times (0–
600 min) at 37uC in PBS-glucose containing 0.25 mM of diamide
(Sigma) or divicine (Serva, Heidelberg). Divicine was activated by
b-glucosidase treatment as previously described [5].
For the inhibition of tyrosine phosphatases, RBCs were
suspended at 30% hematocrit in PBS-glucose and incubated with
1 mM of o-vanadate in presence or absence of oxidants.
For the inhibition of Syk kinase, RBCs were suspended at 30%
hematocrit in PBS-glucose and pre-incubated with 10 mM Syk
inhibitors II and IV (Calbiochem) for 1 h at 37uC before oxidant
treatments. The inhibitors were not washed prior to the oxidant
treatment.
Each reaction was stopped by washing 36in PBS-glucose, and
membranes were prepared as described below. For all the
protocols described above, untreated controls were processed
identically, the only difference being the deletion of the stimulant/
inducer from the incubation.
RBC membrane preparation
Standard hypotonic membranes were prepared at 4uC on ice as
previously described [18]. Briefly: 150 mL of packed RBCs were
diluted into 1.5 mL of cold hemolysis buffer (5 mmol/L sodium
phosphate, 1 mmol/L EDTA, pH 8.0) containing a protease and
phosphatase inhibitor cocktail (Sigma-Aldrich, St.. Louis, MO)
and then washed up to 4 more times in the same buffer (until
membranes became white) in a refrigerated Eppendorf microfuge
at 25,0006g. The preparations were stored frozen at 220uC until
use. Membrane protein content was quantified using the DC
Protein Assay (Biorad).
Figure 3. Confocal microscopy images of control and G6PD deficient RBCs. Panels A D: hemichrome (HCM) autofluorescence; Panels B, E
staining with anti-band 3 antibody (aBd3); Panels C, F staining with anti-phosphotyrosine antibody (apTyr). Panels A, B, C control RBCs (CTRL). Panels
D, E, F G6PD deficient red cells (G
2). Yellow arrows indicate clusters containing hemicromes and co-stained with anti AE1 and anti-phosphotyrosine
antibodies. Bar: 20 mm.
doi:10.1371/journal.pone.0015847.g003
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PLoS ONE | www.plosone.org 5 January 2011 | Volume 6 | Issue 1 | e15847Figure 4. Vesicle characterization. A. Confocal image of isolated vesicles using hemichrome auto-fluorescence (excitation 488 nm, emission 630–
750 nm). Bar: 10 mm. B. SDS PAGE of isolated vesicles and mass spectrometry identification of haemoglobin in the two most intense gel bands
(indicated by the arrows). C. Corresponding western blot with anti AE1 (aBd3) (lanes 1 and 2) and anti-phosphotyrosine (apTyr) (lanes 3 and 4)
antibodies under reducing (DTT) and non reducing conditions. D. Quantification of AE1 contained in vesicles released from G6PD deficient RBCs (G
2).
Quantification of AE1 was performed by IR fluorescence detection of anti-phosphotyrosine and anti-band 3 western blots (Odyssey, Licor, USA) with
Odyssey V3.0 software and expressed as fluorescence arbitrary units. RBCs were treated with 0.25 mM diamide (dia) in presence or absence of Syk
inhibitors 10 mM (Syk I.) at different incubation times (0–600 minutes). Values are means of 3 experiments. The changes caused by Syk inhibitors (after
120 minutes) were significant (p,0.01).
doi:10.1371/journal.pone.0015847.g004
AE1 Phosphorylation in G6PD Deficient Red Cells
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The supernatants of the samples treated as described above,
were collected and centrifuged at 250006g for 10 min at 4uCt o
eliminate spontaneously formed red cell ghosts. Lysis was
quantified by measuring hemoglobin absorbance at 405 nm and
expressed in nmoles/ml. After the addition of phosphatase in-
fhibitors, supernatants were centrifuged for 3 hours at 1000006g
on a refrigerated ultracentrifuge (Beckman) to isolate vesicles.
Protein vesicles were identified by MALDI TOF MS [41].
SDS-PAGE of membrane proteins
Membrane proteins were solubilized in Laemmli Buffer [42]
under reducing (2% DTT) or non-reducing conditions in a volume
ratio of 1:1. SDS-PAGE analysis was conducted by heating the
samples for 5 min at 100uC and loading 20 mg membrane proteins
on the 8% gel for protein staining by blue colloidal Coomassie
[43].
Immunoblot analysis and IR fluorescence detection
Proteins separated by SDS/PAGE were transferred to ni-
trocellulose membranes as previously described [13] and then
probed with either anti-phosphotyrosine antibody (Santa Cruz,
CA) diluted to 1:2000, or with anti-band 3 (AE1) antibody
(Sigma Aldrich) diluted to 1:50000. Secondary antibodies
conjugated to infrared fluorescent dyes excitable at 800 nm
(IRDye 800CW, Li-COR-USA) were then used to visualize the
desired antigens using an 800 nm laser scanner (Odyssey,
Licor, USA). To establish the specificity of anti-phosphotyrosine
antibodies, proteins were dephosphorylated prior to gel electro-
phoresis by incubating the samples for 20 min at 30uCw i t h6mL
(400 units) lambda phosphatase (Santa Cruz, CA) in 50 mM Tris
Buffer pH 7.5, 0.1 mM Na2EDTA, 5 mM dithiothreitol, 2 mM
MnCl2.
Membrane protein cluster separation by size exclusion
chromatography
AE1 was labeled with eosine maleimide and red cell membranes
were fractionated as previously described [34]. With minor
modifications, 1 ml membranes were solubilized in 2 ml extrac-
tion buffer (10 mM Hepes, 130 mM NaCl, 10 mM N-ethylmalei-
mide, 1 mM EDTA, 1 mM PMSF, 1% triton-X100, pH 7.4),
gently shaken for 10 min at 20uC and centrifuged at 13000 rpm
for 5 min in an Eppendorf microfuge. The supernatant was
applied to a 4061 cm column filled with Sepharose CL-6B
equilibrated with a solution containing 10 mM Hepes, 50 mM
NaCl, 0.1% triton-X100 (pH 7.4), at a flow rate of 1 ml/min.
Constant flow was maintained using an HPLC pump. The effluent
was collected in 1 ml fractions. Eosine maleimide fluorescence was
quantified as described [18] and, to measure the percentages of
clustered AE1, the fluorescence measured in the high molecular
weight fraction was expressed as a percentage of the total
fluorescence eluted from the columns. The high molecular weight
fraction was concentrated 10 fold and analysed for immunoblot-
ting with anti-AE1, anti-phosphotyrosine and anti-Syk as de-
scribed above.
Preparation of cells for immunofluorescence
Control and G6PD deficient RBCs were pelleted and washed
twice in PBS 16 containing 5 mM glucose and then fixed for
5 min in 0.5% acrolein in PBS. Cells were rinsed three times then
permeabilized in PBS containing 0.1 M glycine (rinsing buffer)
plus 0.1% Triton X-100 for 5 min and again rinsed 36in rinsing
buffer. To ensure complete neutralization of unreacted aldehydes,
the cells were then incubated in rinsing buffer at room
temperature for 30 min. After incubation, all nonspecific binding
was blocked by incubation again for 60 min in blocking buffer
(PBS containing 0.05 mM glycine, 0.2% fish skin gelatin and
0.05% sodium azide). Staining of fixed, permeabilized RBCs was
performed by using specific antibodies diluted in blocking buffer.
After labeling, resuspended RBCs were allowed to attach to cover
slips coated with polylysine, and the cover slips were mounted by
using Aqua-Mount (Lerner Laboratories, New Haven, CT). The
auto-fluorescence of hemichromes was visualized by exciting at
488 nm and observing their emission in the 630–750 nm range.
Samples were imaged with a Bio-Rad MRC1024 (Bio-Rad)
confocal microscope equipped with a 6061.4 numerical aperture
oil immersion lens.
Assay of hemichromes
Hemichromes were quantified by measuring heme absorbance
at 560, 577 and 630 nm [11] and expressed as nmoles/mL of
solubilised membranes.
Assay of glutathione
GSH estimations were performed using 5,59-dithiobis(2-nitro-
benzoic acid) (DTNB) [44].
Figure 5. Schematic representation of the proposed mechanism. AE1 is dynamically associated with the cytoskeleton through ankyrin
binding in untreated red cells (A). In G6PD deficient RBCs diamide causes irreversible AE1 disulfide cross-linking and its phosphorylation by Syk
kinase, diamide also causes progressive hemichrome formation. In control RBCs AE1 oxidation and phosphorylation are transient and no hemichrome
formation is observed (B). Hemichromes bind to AE1 and promote the clustering of phosphorylated AE1 (C). Large aggregates of AE1 and
hemichromes are released in vesicles (D).
doi:10.1371/journal.pone.0015847.g005
AE1 Phosphorylation in G6PD Deficient Red Cells
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